3.89BMarket Cap
41.47P/E TTM
HAE Balance Sheet
You can check out the annual or quarterly balance sheets of Haemonetics Corp here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing HAE stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Haemonetics Corp Have?
In its most recent quarterly, Haemonetics Corp had 245.44M in cash and cash equivalents.
How Much Are Haemonetics Corp's Total Liabilities?
Haemonetics Corp reported 1.63B in total liabilities as of the latest reported quarter, including 578.11M in current liabilities and 1.05B in non-current liabilities.
What Are Haemonetics Corp's Total Assets?
As of the latest reported quarter, Haemonetics Corp's total assets were 2.40B, consisting of 834.88M in current assets and 1.56B in non-current assets.
How Much Shareholders' Equity Does Haemonetics Corp Have?
Haemonetics Corp reported 796.32M in total shareholders' equity as of the latest reported quarter.